MANELIMAB
UNII U3OZ7HX207

Substance Identification & Data

This profile provides standardized clinical and technical data for Manelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U3OZ7HX207.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2168561-26-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U3OZ7HX207

CAS Registry Number

2168561-26-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MANELIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C156741

National Cancer Institute reference terminology for clinical and research data.

INN ID

11133

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Manelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MANELIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1(239-ALANINE, 240-ALANINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL BCD-135 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BCD-135 LIGHT CHAIN, DIMER

MANELIMAB [INN]